{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:53:23Z","timestamp":1791910403606,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["202208420023"],"award-info":[{"award-number":["202208420023"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118313","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:04:18Z","timestamp":1785942258000},"page":"118313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P1","title":["Identification of CXCL13 as an agonist and CXCL11 as an inverse agonist for the viral G protein-coupled receptor ORF74"],"prefix":"10.1016","volume":"253","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8043-6258","authenticated-orcid":false,"given":"Qianqian","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Van Bosstraeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3872-6558","authenticated-orcid":false,"given":"Steven","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3256-5850","authenticated-orcid":false,"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2524-7264","authenticated-orcid":false,"given":"Tom","family":"Van Loy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118313_b0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0060-9","article-title":"Kaposi sarcoma","volume":"5","author":"Cesarman","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.bcp.2026.118313_b0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrd4189","article-title":"Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?","volume":"13","author":"Vischer","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2026.118313_b0015","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/pharmrev.120.000186","article-title":"Viral G protein\u2013coupled receptors: attractive targets for herpesvirus-associated diseases","volume":"73","author":"De Groof","year":"2021","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2026.118313_b0020","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev-virology-100220-113942","article-title":"Viral G protein\u2013coupled receptors encoded by \u03b2- and \u03b3-herpesviruses","volume":"9","author":"Rosenkilde","year":"2022","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.bcp.2026.118313_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/bph.17379","article-title":"Insight into structural properties of viral G protein\u2010coupled receptors and their role in the viral infection: IUPHAR Review 41","volume":"182","author":"Tsutsumi","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118313_b0030","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1128\/jvi.70.11.8218-8223.1996","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi\u2019s sarcoma and malignant lymphoma","volume":"70","author":"Cesarman","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2026.118313_b0035","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrm908","article-title":"Seven-transmembrane receptors","volume":"3","author":"Pierce","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2026.118313_b0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3389\/fphar.2019.00125","article-title":"GPCR signaling regulation: the role of GRKs and arrestins","volume":"10","author":"Gurevich","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118313_b0045","doi-asserted-by":"crossref","first-page":"8660","DOI":"10.1128\/JVI.75.18.8660-8673.2001","article-title":"Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi\u2019s sarcoma pathogenesis","volume":"75","author":"Pati","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2026.118313_b0050","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.167.1.505","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-\u03baB and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant","volume":"167","author":"Schwarz","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2026.118313_b0055","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1038\/sj.onc.1210817","article-title":"An NF-\u03baB gene expression signature contributes to Kaposi\u2019s sarcoma virus vGPCR-induced direct and paracrine neoplasia","volume":"27","author":"Martin","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118313_b0060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.191.3.445","article-title":"Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling kaposi\u2019s sarcoma","volume":"191","author":"Yang","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2026.118313_b0065","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.4049\/jimmunol.174.6.3686","article-title":"The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of kaposi\u2019s sarcoma","volume":"174","author":"Jensen","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2026.118313_b0070","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1172\/JCI13622","article-title":"Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity","volume":"108","author":"Holst","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118313_b0075","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.onc.1207021","article-title":"The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells","volume":"23","author":"Cannon","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.118313_b0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/385347a0","article-title":"Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation","volume":"385","author":"Arvanitakis","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2026.118313_b0085","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1074\/jbc.274.2.956","article-title":"Agonists and inverse agonists for the herpesvirus 8-encoded constitutively active seven-transmembrane oncogene product, ORF-74","volume":"274","author":"Rosenkilde","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118313_b0090","doi-asserted-by":"crossref","first-page":"31327","DOI":"10.1074\/jbc.274.44.31327","article-title":"The N terminus of kaposi\u2019s sarcoma-associated herpesvirus g protein-coupled receptor is necessary for high affinity chemokine binding but not for constitutive activity","volume":"274","author":"Ho","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118313_b0095","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/mol.57.3.602","article-title":"Potency of ligands correlates with affinity measured against agonist and inverse agonists but not against neutral ligand in constitutively active chemokine receptor","volume":"57","author":"Rosenkilde","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118313_b0100","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.188.2.405","article-title":"Human Interferon-\u03b3\u2013inducible Protein 10 (IP-10) Inhibits Constitutive Signaling of Kaposi\u2019s Sarcoma\u2013associated Herpesvirus G Protein\u2013coupled Receptor","volume":"188","author":"Geras-Raaka","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bcp.2026.118313_b0105","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1172\/JCI4461","article-title":"Chemokines activate Kaposi\u2019s sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture","volume":"102","author":"Gershengorn","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118313_b0110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1006\/bbrc.1998.9557","article-title":"Kaposi\u2019s Sarcoma-Associated Herpesvirus (KSHV) Chemokine vMIP-II and Human SDF-1\u03b1 Inhibit Signaling by KSHV G Protein-coupled Receptor","volume":"253","author":"Geras-Raaka","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2026.118313_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124486","article-title":"The viral G protein-coupled receptor ORF74 Hijacks \u03b2-arrestins for endocytic trafficking in response to human chemokines","volume":"10","author":"de Munnik","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2026.118313_b0120","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1186\/s12964-025-02546-9","article-title":"Human and viral chemokines differentially modulate G protein signaling, \u03b2-arrestin recruitment and chemotaxis mediated by the viral G protein-coupled receptor ORF74","volume":"23","author":"Kong","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.bcp.2026.118313_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114565","article-title":"Biological characterization of ligands targeting the human CC chemokine receptor 8 (CCR8) reveals the biased signaling properties of small molecule agonists","volume":"188","author":"Liu","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118313_b0130","first-page":"56780","article-title":"A kinetic fluorescence-based Ca2+ mobilization assay to identify G protein-coupled receptor agonists, antagonists, and allosteric modulators","author":"Claes","year":"2018","journal-title":"JoVE"},{"key":"10.1016\/j.bcp.2026.118313_b0135","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1021\/acschembio.5b00753","article-title":"NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells","volume":"11","author":"Dixon","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118313_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1133394","article-title":"New pairings and deorphanization among the atypical chemokine receptor family \u2014 physiological and clinical relevance","volume":"14","author":"Szpakowska","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118313_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1297596","article-title":"Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5)","volume":"14","author":"Bonnavion","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118313_b0150","doi-asserted-by":"crossref","unstructured":"M. Meyrath, C.B. Palmer, J.-M. Plesseria, J. Darcis, D. Nesheva, M. Thelen, D.F. Legler, R. Leurs, J. Hanson, M. Szpakowska, A. Chevign\u00e9, ACKR5\/GPR182 is a scavenger receptor for the atypical chemokine CXCL17, GPR15L and various endogenous peptides, (2024). https:\/\/doi.org\/10.1101\/2024.06.01.596940.","DOI":"10.1101\/2024.06.01.596940"},{"key":"10.1016\/j.bcp.2026.118313_b0155","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1016\/j.cell.2025.03.046","article-title":"Encoding and decoding selectivity and promiscuity in the human chemokine-GPCR interaction network","volume":"188","author":"Kleist","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118313_b0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2403217121","article-title":"Structural insights into KSHV-GPCR constitutive activation and CXCL1 chemokine recognition","volume":"121","author":"Liu","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2026.118313_b0165","doi-asserted-by":"crossref","first-page":"8403","DOI":"10.1038\/s41467-025-63457-4","article-title":"Structural basis for ligand promiscuity and high signaling activity of Kaposi\u2019s Sarcoma-associated Herpesvirus-encoded GPCR","volume":"16","author":"Park","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2026.118313_b0170","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1099\/vir.0.82375-0","article-title":"Induction of chemokine production by latent Kaposi\u2019s sarcoma-associated herpesvirus infection of endothelial cells","volume":"88","author":"Xu","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.bcp.2026.118313_b0175","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1128\/JVI.01871-08","article-title":"Gene Regulation and functional alterations induced by kaposi\u2019s sarcoma-associated herpesvirus-encoded ORFK13\/vFLIP in Endothelial Cells","volume":"83","author":"Sakakibara","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2026.118313_b0180","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1182\/blood-2008-10-186403","article-title":"Induction of CCL20 production by Kaposi sarcoma\u2013associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-\u03baB activation","volume":"113","author":"Punj","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2026.118313_b0185","doi-asserted-by":"crossref","first-page":"e01277","DOI":"10.1128\/mBio.01277-14","article-title":"Human Herpesvirus 8 Induces Polyfunctional B Lymphocytes That Drive Kaposi\u2019s Sarcoma","volume":"5","author":"Knowlton","year":"2014","journal-title":"mBio"},{"key":"10.1016\/j.bcp.2026.118313_b0190","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00917-17","article-title":"Kaposi\u2019s Sarcoma-Associated Herpesvirus Increases PD-L1 and Proinflammatory Cytokine Expression in Human Monocytes","volume":"8","author":"Host","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.bcp.2026.118313_b0195","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28020","article-title":"CXCL1 confers a survival advantage in Kaposi\u2019s sarcoma\u2010associated herpesvirus\u2010infected human endothelial cells through STAT3 phosphorylation","volume":"95","author":"Lee","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bcp.2026.118313_b0200","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1128\/JVI.02590-07","article-title":"Upregulation of the TLR3 pathway by kaposi\u2019s sarcoma-associated herpesvirus during primary infection","volume":"82","author":"West","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.bcp.2026.118313_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108254","article-title":"The dual role of the CXCL9\/10\/11-CXCR3 axis in the tumor immune microenvironment: Mechanisms, therapeutic implications, and clinical translation","volume":"229","author":"Liu","year":"2026","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2026.118313_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188799","article-title":"CXCL13-CXCR5 axis: Regulation in inflammatory diseases and cancer","volume":"1877","author":"Wang","year":"2022","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"10.1016\/j.bcp.2026.118313_b0215","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70392","article-title":"Development and Characterization of an Inducible Bacterial Artificial Chromosome System for Studying Lytic Replication and Pathogenesis of Kaposi\u2019s Sarcoma\u2010Associated Herpesvirus","volume":"97","author":"Xu","year":"2025","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bcp.2026.118313_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118797","article-title":"Targeting of Kaposi\u2019s sarcoma-associated herpesvirus by immunotoxins directed against the viral G protein-coupled receptor, ORF74","volume":"195","author":"Kildedal","year":"2026","journal-title":"Biomed. Pharmacother."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:24:21Z","timestamp":1791908661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":44,"alternative-id":["S0006295226006520"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118313","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of CXCL13 as an agonist and CXCL11 as an inverse agonist for the viral G protein-coupled receptor ORF74","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118313"}}